Cures Act ensures U.S. will continue to outperform Canada in approving new medicines

Last month, President Obama signed the last bill of his presidency, the 21st Century Cures Act. The most important part of this bill is reform of the regulatory processes at the Food and Drug Administration (FDA), which will speed up innovation and patient access to new medicines.In 2013, the Fraser Institute published research showing Health Canada’s Therapeutic Products Directorate, which grants permission for new medicines to be used in Canada, lagged behind its European counterparts and the FDA. Because of the Cures Act, the gap in performance between Canada and the U.S. is likely to get significantly worse.The Act combines

Read More - The Fraser Institute